Quick Answer
NEOGENOMICS INC reported Gross Profit of $314.29 million for the year ending 2025.
- NEOGENOMICS INC showed an increase of +8.3% in Gross Profit from 2024 to 2025.
- This data is from NEOGENOMICS INC's annual report (Form 10-K), filed with the SEC on February 17, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2014: $8.71 million | Q2 2014: $10.24 million | Q3 2014: $10.29 million | Q4 2014: $11.47 million | Q1 2015: $9.54 million | Q2 2015: $10.81 million | Q3 2015: $11.17 million | Q4 2015: $12.23 million | Q1 2016: $27.17 million | Q2 2016: $28.61 million | Q3 2016: $27.35 million | Q4 2016: $27.26 million | Q1 2017: $22.95 million | Q2 2017: $27.35 million | Q3 2017: $24.90 million | Q4 2017: $26.76 million | Q1 2018: $27.30 million | Q2 2018: $30.53 million | Q3 2018: $32.32 million | Q4 2018: $37.11 million | Q1 2019: $47.12 million | Q2 2019: $48.97 million | Q3 2019: $50.83 million | Q4 2019: $49.92 million | Q1 2020: $46.37 million | Q2 2020: $28.01 million | Q3 2020: $54.07 million | Q1 2021: $41.57 million | Q2 2021: $52.99 million | Q3 2021: $47.24 million | Q1 2022: $38.23 million | Q2 2022: $43.95 million | Q3 2022: $48.89 million | Q1 2023: $54.81 million | Q2 2023: $59.89 million | Q3 2023: $62.31 million | Q1 2024: $65.47 million | Q2 2024: $72.49 million | Q3 2024: $74.88 million | Q1 2025: $73.25 million | Q2 2025: $77.26 million | Q3 2025: $80.45 million.
- Over the full 16 years of available data (2010 to 2025), NEOGENOMICS INC's Gross Profit has grown by 1,891.3%.
- Historical annual values: Fiscal year 2025: $314.29 million | Fiscal year 2024: $290.10 million | Fiscal year 2023: $244.60 million | Fiscal year 2022: $187.90 million | Fiscal year 2021: $187.06 million | Fiscal year 2020: $185.89 million | Fiscal year 2019: $196.84 million | Fiscal year 2018: $127.27 million | Fiscal year 2017: $101.96 million | Fiscal year 2016: $98.10 million | Fiscal year 2015: $43.76 million | Fiscal year 2014: $40.71 million | Fiscal year 2013: $31.74 million | Fiscal year 2012: $26.84 million | Fiscal year 2011: $19.43 million | Fiscal year 2010: $15.78 million.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: